Literature DB >> 26261684

Inhibitory effect of chloroquine derivatives on presenilin 1 and ubiquilin 1 expression in Alzheimer's disease.

Fang-Fang Zhang1, Jing Li1.   

Abstract

Alzheimer's disease is the common cause of dementia characterized by the accumulation of amyloid-β produced by breakage of amyloid-β precursor protein (APP). The present study was designed to synthesize and investigate the effect of chloroquine derivatives on the expression of presenilin. Among the five chloroquine derivatives (D1, D2, D3, D4 and D5) synthesized, D5 with diisopropyl substitution was found to be most effect. The results from western blot analysis showed the inhibition of presenilin 1 protein expression on treatment with chloroquine derivative D5 in Daudi cells. The results were also confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR). It was observed that chloroquine derivative D5 downregulates presenilin expression via the inhibition of ubiquilin 1 expression. Thus our study demonstrates that chloroquine derivative D5 treatment can have preventive against Alzheimer's disease.

Entities:  

Keywords:  Chloroquine; diisopropyl substitution; inhibition; presenilin; ubiquilin 1

Mesh:

Substances:

Year:  2015        PMID: 26261684      PMCID: PMC4526018     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein.

Authors:  Can Zhang; Andrew Browne; Daniel Child; Rudolph E Tanzi
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

3.  Assessment of chloroquine treatment for modulating autophagy flux in brain of WT and HD mice.

Authors:  Petr Vodicka; Junghyun Lim; Dana T Williams; Kimberly B Kegel; Kathryn Chase; Hyunsun Park; Deanna Marchionini; Stephen Wilkinson; Tania Mead; Helen Birch; Dawn Yates; Kathy Lyons; Celia Dominguez; Maria Beconi; Zhenyu Yue; Neil Aronin; Marian DiFiglia
Journal:  J Huntingtons Dis       Date:  2014

4.  Event-related potential markers of brain changes in preclinical familial Alzheimer disease.

Authors:  Y T Quiroz; B A Ally; K Celone; J McKeever; A L Ruiz-Rizzo; F Lopera; C E Stern; A E Budson
Journal:  Neurology       Date:  2011-07-20       Impact factor: 9.910

5.  Family-based association between Alzheimer's disease and variants in UBQLN1.

Authors:  Lars Bertram; Mikko Hiltunen; Michele Parkinson; Martin Ingelsson; Christoph Lange; Karunya Ramasamy; Kristina Mullin; Rashmi Menon; Andrew J Sampson; Monica Y Hsiao; Kathryn J Elliott; Gonül Velicelebi; Thomas Moscarillo; Bradley T Hyman; Steven L Wagner; K David Becker; Deborah Blacker; Rudolph E Tanzi
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

6.  New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.

Authors:  David A Kocisko; Gerald S Baron; Richard Rubenstein; Jiancao Chen; Salomon Kuizon; Byron Caughey
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.

Authors:  M Garcia-Alloza; L A Borrelli; A Rozkalne; B T Hyman; B J Bacskai
Journal:  J Neurochem       Date:  2007-04-30       Impact factor: 5.372

Review 8.  Prion-like Mechanisms in Alzheimer's Disease.

Authors:  Rui-Hua Yin; Lan Tan; Teng Jiang; Jin-Tai Yu
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

9.  Lysosomotropic agents as HCV entry inhibitors.

Authors:  Usman A Ashfaq; Tariq Javed; Sidra Rehman; Zafar Nawaz; Sheikh Riazuddin
Journal:  Virol J       Date:  2011-04-12       Impact factor: 4.099

10.  Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation.

Authors:  A L Mah; G Perry; M A Smith; M J Monteiro
Journal:  J Cell Biol       Date:  2000-11-13       Impact factor: 10.539

View more
  2 in total

Review 1.  Primaquine derivatives: Modifications of the terminal amino group.

Authors:  Branka Zorc; Ivana Perković; Kristina Pavić; Zrinka Rajić; Maja Beus
Journal:  Eur J Med Chem       Date:  2019-08-23       Impact factor: 6.514

2.  Decreased expression of ubiquilin‑1 following neonatal hypoxia‑ischemic brain injury in mice.

Authors:  Li Luo; Yilin Liu; Xing Tu; Xuxin Ren; Wenyan Zhao; Jing Liu; Li Zhang; Weiqiang Chen; Pei Zhang; Weicai Wang; Lanhai Lü; Mengxia Wang
Journal:  Mol Med Rep       Date:  2019-04-15       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.